Standard BioTools Inc. ( LAB) - Key Metrics
LAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | $0.05 | $0 | $0 |
| 2025Q3 | $0.05 | -$0.09 | -$0.06 | -$0.06 |
| 2025Q2 | $0.06 | -$0.09 | -$0.05 | -$0.06 |
| 2025Q1 | $0.11 | -$0.07 | -$0.08 | -$0.09 |
LAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 6.39 |
| 2025Q3 | ? | -3.59 |
| 2025Q2 | ? | -3.41 |
| 2025Q1 | ? | -3.92 |
LAB
Price: $0.84
52 week price:
Earnings Per Share: -0.13 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 454.8 million